Is COVID surveillance collapsing in low-income countries? WHO raises early red flags
WHO warns COVID variant surveillance is weakening in low-income countries amid rising test positivity. Experts call for urgent funding and data-sharing reform. Read More
NB.1.8.1 variant triggers global COVID-19 surge amid endemic transition
NB.1.8.1 variant drives global COVID-19 surge; China, Australia report highest transmission. WHO classifies risk as low but urges continued vaccine surveillance. Read More
JN.1 variant: Why it still dominates global COVID-19 cases in mid-2025
JN.1 remains the most dominant COVID-19 variant in mid-2025. Explore why it still leads global cases, what WHO and CDC recommend, and how vaccines are ... Read More
NB.1.8.1 triggers COVID crisis in Hong Kong—Global agencies on high alert
NB.1.8.1 variant causes Hong Kong’s worst COVID surge in a year; WHO monitors spread globally as deaths and hospitalizations rise among elderly. Read More
WHO adds NB.1.8.1 to global variant monitoring list as spread confirmed in 22 countries
WHO lists NB.1.8.1 as Variant Under Monitoring; global surveillance expands via CoViNet as early spread confirmed in over 22 countries. Read More
Booster drop-off alarms health officials as NB.1.8.1 and LP.8.1 variants gain ground
WHO flags sharp global drop in COVID-19 booster uptake amid rising NB.1.8.1 and LP.8.1 variants; CDC, India, U.K. ramp up fall vaccination planning. Read More
NB.1.8.1 variant monitored by WHO as global spread accelerates in May 2025
NB.1.8.1 spreads across U.S., India, and China in May 2025; WHO designates as Variant Under Monitoring. No rise in severity reported yet. Read More
China reports HMPV rise as seasonal surge amid winter respiratory illness spike
China has reported a significant rise in human metapneumovirus (HMPV) cases this winter, particularly across its northern regions, where the colder climate often contributes to ... Read More
Surge in HMPV cases prompts UK health experts to call for China’s transparency
A sharp increase in human metapneumovirus (HMPV) infections has raised alarms among UK health authorities, who are urging China to release detailed data on its ... Read More
FDA shocks Neurotech with rejection of orphan drug status for life-changing PANDAS/PANS treatment
Neurotech International Limited is facing an uphill battle after the United States Food and Drug Administration (FDA) declined the company's request for orphan drug status ... Read More